FDA OKs trial of pig livers as dialysis-like treatment for liver failure

U.S. researchers are about to test if livers from gene-edited pigs could treat people with sudden liver failure — not with a transplant but temporarily attached outside the body. Pig producer eGenesis announced Tuesday that the Food and Drug Administration is allowing a clinical trial in up to 20 severely ill patients. The pig liver would filter patients’ blood, with help from a device made by Britain’s OrganOx, so their own liver could rest. It’s the latest step in attempts to use gene-edited pig organs to save human lives.

Thank you for reading this post, don't forget to subscribe!